These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 29168983)
1. Reverse cascade screening for familial hypercholesterolemia in high-risk Chinese families. Wu X; Pang J; Wang X; Peng J; Chen Y; Wang S; Watts GF; Lin J Clin Cardiol; 2017 Nov; 40(11):1169-1173. PubMed ID: 29168983 [TBL] [Abstract][Full Text] [Related]
2. Homozygous familial hypercholesterolaemia in Vietnam: Case series, genetics and cascade testing of families. Truong TH; Kim NT; Nguyen MNT; Pang J; Hooper AJ; Watts GF; Do DL Atherosclerosis; 2018 Oct; 277():392-398. PubMed ID: 30270076 [TBL] [Abstract][Full Text] [Related]
3. Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature review. Groselj U; Kovac J; Sustar U; Mlinaric M; Fras Z; Podkrajsek KT; Battelino T Atherosclerosis; 2018 Oct; 277():383-391. PubMed ID: 30270075 [TBL] [Abstract][Full Text] [Related]
4. Spectrum of mutations in homozygous familial hypercholesterolemia in India, with four novel mutations. Setia N; Saxena R; Arora A; Verma IC Atherosclerosis; 2016 Dec; 255():31-36. PubMed ID: 27816806 [TBL] [Abstract][Full Text] [Related]
5. Long-Term Cardiovascular Risk in Heterozygous Familial Hypercholesterolemia Relatives Identified by Cascade Screening. Kjærgaard KA; Christiansen MK; Schmidt M; Olsen MS; Jensen HK J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28652386 [TBL] [Abstract][Full Text] [Related]
6. Cascade Screening for Familial Hypercholesterolemia in South Africa: The Wits FIND-FH Program. Raal FJ; Bahassi EM; Stevens B; Turner TA; Stein EA Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2747-2755. PubMed ID: 32878475 [TBL] [Abstract][Full Text] [Related]
7. The evaluation of cascade testing for familial hypercholesterolemia. Morris JK; Wald DS; Wald NJ Am J Med Genet A; 2012 Jan; 158A(1):78-84. PubMed ID: 22139944 [TBL] [Abstract][Full Text] [Related]
8. Novel combined variants of LDLR and LDLRAP1 genes causing severe familial hypercholesterolemia. Alnouri F; Athar M; Al-Allaf FA; Abduljaleel Z; Taher MM; Bouazzaoui A; Al Ammari D; Karrar H; Albabtain M Atherosclerosis; 2018 Oct; 277():425-433. PubMed ID: 30270081 [TBL] [Abstract][Full Text] [Related]
9. Clinical phenotype in relation to the distance-to-index-patient in familial hypercholesterolemia. Besseling J; Huijgen R; Martin SS; Hutten BA; Kastelein JJ; Hovingh GK Atherosclerosis; 2016 Mar; 246():1-6. PubMed ID: 26745182 [TBL] [Abstract][Full Text] [Related]
10. Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia. Ellis KL; Pérez de Isla L; Alonso R; Fuentes F; Watts GF; Mata P J Am Coll Cardiol; 2019 Mar; 73(9):1029-1039. PubMed ID: 30846097 [TBL] [Abstract][Full Text] [Related]
11. Health related quality of life in individuals at high risk for familial hypercholesterolemia undergoing genetic cascade screening in Brazil. Souto AC; Miname MH; Fukushima J; Jannes CE; Krieger JE; Hagger M; Pereira AC; Santos RD Atherosclerosis; 2018 Oct; 277():464-469. PubMed ID: 30270086 [TBL] [Abstract][Full Text] [Related]
12. Independent Severe Cases of Heterozygous Familial Hypercholesterolemia Caused by the W483X and Novel W483G Mutations in the Low-Density Lipoprotein Receptor Gene That Were Clinically Diagnosed as Homozygous Cases. Cheng S; Wu Y; Wen W; An M; Gao Y; Wang L; Han X; Shang H Genet Test Mol Biomarkers; 2019 Jun; 23(6):401-408. PubMed ID: 31161821 [No Abstract] [Full Text] [Related]
13. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene. Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584 [TBL] [Abstract][Full Text] [Related]
14. Familial Hypercholesterolemia Phenotype in Chinese Patients Undergoing Coronary Angiography. Li JJ; Li S; Zhu CG; Wu NQ; Zhang Y; Guo YL; Gao Y; Li XL; Qing P; Cui CJ; Xu RX; Jiang ZW; Sun J; Liu G; Dong Q Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):570-579. PubMed ID: 27932355 [TBL] [Abstract][Full Text] [Related]
15. Phenotypic variation in heterozygous familial hypercholesterolemia: a comparison of Chinese patients with the same or similar mutations in the LDL receptor gene in China or Canada. Pimstone SN; Sun XM; du Souich C; Frohlich JJ; Hayden MR; Soutar AK Arterioscler Thromb Vasc Biol; 1998 Feb; 18(2):309-15. PubMed ID: 9484998 [TBL] [Abstract][Full Text] [Related]
16. Low-density lipoprotein levels and not mutation status predict intima-media thickness in familial hypercholesterolemia. Fahed AC; Habib RH; Nemer GM; Azar ST; Andary RR; Arabi MT; Moubarak EM; Bitar FF; Haddad FF Ann Vasc Surg; 2014 Feb; 28(2):421-6. PubMed ID: 24120234 [TBL] [Abstract][Full Text] [Related]
17. Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies. Nherera L; Marks D; Minhas R; Thorogood M; Humphries SE Heart; 2011 Jul; 97(14):1175-81. PubMed ID: 21685482 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience. Bell DA; Pang J; Burrows S; Bates TR; van Bockxmeer FM; Hooper AJ; O'Leary P; Burnett JR; Watts GF Atherosclerosis; 2015 Mar; 239(1):93-100. PubMed ID: 25585028 [TBL] [Abstract][Full Text] [Related]
19. Cascade screening and treatment of children with familial hypercholesterolemia in Turkey. Kose E; Kose M; Ozturk SI; Ozcan E; Onay H; Ozkan B J Pediatr Endocrinol Metab; 2020 Aug; 33(10):1251-1256. PubMed ID: 32829317 [TBL] [Abstract][Full Text] [Related]